Advertisement
Dr. Xiao-Dong Huang works at the University of Waterloo (UW) as theDirector of International Collaboration Education Program of China 2+2 andResearch Associate Professor of the Department of Biology. The biotechnologyresearch group composed of Dr. Huang, Dr. Glick and Dr. Greenberg hasdeveloped several bio-products and bio-techniques that have been successfullyapplied to the agricultural and environmental industry.
Advertisement
During the meeting, Dr. Huang agreed with Mr. Wei, Li that great potentialexits for collaboration between the UW group and Kiwa on research anddevelopment of PGPR based bio-products and biotechnology. Dr. Huang presentedinformation about their commercial applications in agriculture andenvironment, including successful applications in petroleum and saltcontaminated soil remediation. The results from commercial field applicationshave shown their distinct positive effects on petroleum degradation in oilfields and vegetation recovery from salt impacted soils in Western Canada. Inaddition, Dr, Huang has also identified that PGPR based technology can be usedin commercial operations in agricultural production, including:
After discussion, Dr. Huang looked forward to meeting with Pro. Qi Wang,Director of Kiwa-CAU R&D Center and to establishing collaboration relationswith Kiwa Corp.
Mr. Wei Li, Chairman of the Board and CEO of the Company, stated, "Thiswas a successful meeting, both parties agreed and are willing to cooperate.Based on the established firm strategic cooperative relations, on agriculturalindustry penetration and development, with China Agricultural Ministry, ChinaGreen Food Association and other institutions, together with the technologicalsupport from China Agriculture University, we expect to build a cooperativerelation with Dr. Huang's research team to develop and introduce some new bio-tech products with significant commercial value meeting the marketrequirements in China."
ABOUT KIWA BIO-TECH PRODUCTS GROUP CORPORATION
The Company develops, manufactures, distributes and markets innovative,cost-effective, and environmentally safe bio-technological products foragricultural and natural resources and environmental conservation. The Companyhas acquired the rights to manufacture and market AF-01 Anti-viral AerosolAgent for use in preventing (blocking) bird-flu disease in Chinese andinternational markets. The Company has excellent relations with governmentauthorities in China and has developed several innovative, high marginproducts, while continuing to grow through internal and external productdevelopment. The Company's products are designed to enhance the quality ofhuman life by increasing the value, quality and productivity of crops anddecreasing the negative environmental impact of chemicals and other wastes.For more information about the Company, please review documents filed with theSEC (www.sec.gov) or visit the Company's website at www.kiwabiotech.com.
This press release contains information that constitutes forward-lookingstatements made pursuant to the safe harbor provisions of the PrivateSecurities Litigation Reform Act of 1995. Any such forward-looking statementsinvolve risk and uncertainties that could cause actual results to differmaterially from any future results described by the forward-lookingstatements. Risk factors that could contribute to such differences includethose matters more fully disclosed in the Com
